{"id":"W2759131576","doi":"10.1016/j.cjca.2017.07.336","title":"EMPAGLIFLOZIN (EMPA) REDUCES HEART FAILURE OUTCOMES IRRESPECTIVE OF BLOOD PRESSURE (BP), LOW DENSITY LIPOPROTEIN CHOLESTEROL (LDL-C) AND HBA1C CONTROL","year":2017,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"ca_institutions":"Toronto Public Health","funders":"","keywords":"EMPA; Medicine; Empagliflozin; Internal medicine; Blood pressure; Diabetes mellitus; Cardiology; Heart failure; Type 2 diabetes; Placebo; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003056679,0.0001682082,0.0005571491,0.0001549929,0.0001195221,0.0002364596,0.0001138249,0.0002584195,0.001501983],"category_scores_gemma":[0.0006308832,0.0001081374,0.0003422489,0.0001389799,0.0001121873,0.000273549,0.0002201097,0.0008249399,0.0002730133],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001737273,"about_ca_system_score_gemma":0.0002753539,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009940275,"about_ca_topic_score_gemma":0.002222116,"domain_scores_codex":[0.999917,0.00001796141,0.000007660529,0.00001177128,0.00002636696,0.00001931363],"domain_scores_gemma":[0.9998222,0.00004353643,0.00004508872,0.00001310956,0.00002215161,0.00005391445],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.06721462,0.004202318,0.0394792,0.001148014,0.001767352,0.0004288855,0.00006505035,0.0008893445,0.02603866,0.0006331115,0.02024711,0.8378864],"study_design_scores_gemma":[0.04409446,0.03974014,0.8507723,0.0006579592,0.004598728,0.002650673,0.0001517687,0.00811152,0.01507646,0.001778916,0.03228422,0.00008291664],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9674425,0.01901216,0.001319404,0.002511246,0.0003762671,0.00007496618,0.0006652959,0.0002854894,0.008312614],"genre_scores_gemma":[0.9876961,0.006001581,0.001577965,0.001566201,0.0003737745,0.00003427072,0.0005452676,0.00001024127,0.002194631],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001501983,"threshold_uncertainty_score":0.005024612,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01117903167927045,"score_gpt":0.2693614612146391,"score_spread":0.2581824295353686,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}